Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
Provided By GlobeNewswire
Last update: Aug 7, 2025
FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the second quarter ended June 30, 2025, and provided business updates.
Read more at globenewswire.com
